Interaction between mutations and regulation of gene expression during development of de novo antibiotic resistance

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 8, 2014, Pages 4371-4379

  Händel, Nadine ^a   Schuurmans, Jasper M ^a   Feng, Yanfang ^a   Brul, Stanley ^a   Ter Kuile, Benno H ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Netherlands Food and Consumer Product Safety Authority   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; CARRIER PROTEIN; ENROFLOXACIN; ESCHERICHIA COLI PROTEIN; QUINOLONE DERIVATIVE; TETRACYCLINE;

ADAPTATION; ANTIBIOTIC RESISTANCE; DNA REPAIR; DNA SEQUENCE; DRUG EFFECTS; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; TIME;

ADAPTATION, PHYSIOLOGICAL; AMOXICILLIN; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FLUOROQUINOLONES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA; SOS RESPONSE (GENETICS); TETRACYCLINE; TIME FACTORS;

EID: 84905393512     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02892-14     Document Type: Article

References (41)

1. Andersson DI, Hughes D. 2010. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8:260-271. http://dx.doi.org/10.1038/nrmicro2319.
2. Depardieu F, Podglajen I, Leclercq R, Collatz E, Courvalin P. 2007. Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 20:79-114. http://dx.doi.org/10.1128/CMR.00015-06.
3. Martinez JL, Fajardo A, Garmendia L, Hernandez A, Linares JF, Martinez-Solano L, Sanchez MB. 2009. A global view of antibiotic resistance. FEMS Microbiol. Rev. 33:44-65. http://dx.doi.org/10.1111/j.1574-6976.2008.00142. x.
4. Martinez JL, Rojo F. 2011. Metabolic regulation of antibiotic resistance. FEMS Microbiol. Rev. 35:768-789. http://dx.doi.org/10.1111/j.1574-6976.2011. 00282.x.
5. Toprak E, Veres A, Michel JB, Chait R, Hartl DL, Kishony R. 2012. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat. Genet. 44:101-105. http://dx.doi.org/10.1038/ng.1034.
6. Kohanski MA, Depristo MA, Collins JJ. 2010. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol. Cell 37:311-320. http://dx.doi.org/10.1016/j.molcel.2010.01.003.
7. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130:797-810. http://dx.doi.org/10.1016/j.cell.2007.06.049.
8. Fang FC. 2013. Antibiotic and ROS linkage questioned. Nat. Biotechnol. 31:415-416. http://dx.doi.org/10.1038/nbt.2574.
9. Van Der Horst MA, Schuurmans JM, Smid MC, Koenders BB, Ter Kuile BH. 2011. De novo acquisition of resistance to three antibiotics by Escherichia coli. Microb. Drug Resist. 17:141-147. http://dx.doi.org/10.1089/mdr.2010.0101.
10. Händel N, Schuurmans JM, Brul S, Ter Kuile BH. 2013. Compensation of the metabolic costs of antibiotic resistance by physiological adaptation in Escherichia coli. Antimicrob. Agents Chemother. 57:3752-3762. http://dx.doi.org/10.1128/AAC.02096-12.
11. Beaber JW, Hochhut B, Waldor MK. 2004. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427:72-74. http://dx.doi.org/10.1038/nature02241.
12. Corvec S, Caroff N, Espaze E, Marraillac J, Reynaud A. 2002. -11 Mutation in the ampC promoter increasing resistance to beta-lactams in a clinical Escherichia coli strain. Antimicrob. Agents Chemother. 46:3265-3267. http://dx.doi.org/10.1128/AAC.46.10.3265-3267.2002.
13. Drlica K, Hiasa H, Kerns R, Malik M, Mustaev A, Zhao X. 2009. Quinolones: action and resistance updated. Curr. Top. Med. Chem. 9:981-998. http://dx.doi.org/10.2174/156802609789630947.
14. Evans C G T, Herbert D, Tempest DW. 1970. The continuous culture of microorganisms. II. Construction of a chemostat. In Norris JR, Ribbons DW (ed), Methods in microbiology, vol 2. Academic Press, London, United Kingdom.
15. Schuurmans JM, Nuri Hayali AS, Koenders BB, Ter Kuile BH. 2009. Variations in MIC value caused by differences in experimental protocol. J. Microbiol. Methods 79:44-47. http://dx.doi.org/10.1016/j.mimet.2009.07.017.
16. Schuurmans JM, Van Hijum SA, Piet JR, Handel N, Smelt J, Brul S, Ter Kuile BH. 2014. Effect of growth rate and selection pressure on rates of transfer of an antibiotic resistance plasmid between E. coli strains. Plasmid 72C:1-8. http://dx.doi.org/10.1016/j.plasmid.2014.01.002.
17. Kern R, Malki A, Abdallah J, Tagourti J, Richarme G. 2007. Escherichia coli HdeB is an acid stress chaperone. J. Bacteriol. 189:603-610. http://dx.doi.org/10.1128/JB.01522-06.
18. Tramonti A, De Canio M, Delany I, Scarlato V, De Biase D. 2006. Mechanisms of transcription activation exerted by GadX and GadW at the gadA and gadBC gene promoters of the glutamate-based acid resistance system in Escherichia coli. J. Bacteriol. 188:8118-8127. http://dx.doi.org/10.1128/JB. 01044-06.
19. Eicher T, Brandstatter L, Pos KM. 2009. Structural and functional aspects of the multidrug efflux pump AcrB. Biol. Chem. 390:693-699. http://dx.doi.org/10.1515/BC.2009.090.
20. Grundstrom T, Jaurin B. 1982. Overlap between ampC and frd operons on the Escherichia coli chromosome. Proc. Natl. Acad. Sci. U. S. A. 79:1111-1115. http://dx.doi.org/10.1073/pnas.79.4.1111.
21. Jaurin B, Grundstrom T, Normark S. 1982. Sequence elements determining ampC promoter strength in E. coli. EMBO J. 1:875-881.
22. Tracz DM, Boyd DA, Hizon R, Bryce E, McGeer A, Ofner-Agostini M, Simor AE, Paton S, Mulvey MR; Canadian Nosocomial Infection Surveillance Program. 2007. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates. FEMS Microbiol. Lett. 270:265-271. http://dx.doi.org/10.1111/j.1574-6968.2007.00672.x.
23. Kawecki TJ, Lenski RE, Ebert D, Hollis B, Olivieri I, Whitlock MC. 2012. Experimental evolution. Trends Ecol. Evol. 27:547-560. http://dx.doi.org/10. 1016/j.tree.2012.06.001.
24. Lang GI, Rice DP, Hickman MJ, Sodergren E, Weinstock GM, Botstein D, Desai MM. 2013. Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations. Nature 500:571-574. http://dx.doi.org/10.1038/ nature12344.
25. Wielgoss S, Barrick JE, Tenaillon O, Wiser MJ, Dittmar WJ, Cruveiller S, Chane-Woon-Ming B, Medigue C, Lenski RE, Schneider D. 2013. Mutation rate dynamics in a bacterial population reflect tension between adaptation and genetic load. Proc. Natl. Acad. Sci. U. S. A. 110:222-227. http://dx.doi.org/10. 1073/pnas.1219574110.
26. Marcusson LL, Frimodt-Moller N, Hughes D. 2009. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog. 5:e1000541. http://dx.doi.org/10.1371/journal.ppat.1000541.
27. Heddle J, Maxwell A. 2002. Quinolone-binding pocket of DNA gyrase: role of GyrB. Antimicrob. Agents Chemother. 46:1805-1815. http://dx.doi.org/10.1128/ AAC.46.6.1805-1815.2002.
28. Everett MJ, Jin YF, Ricci V, Piddock LJ. 1996. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Chemother. 40:2380-2386.
29. Madurga S, Sanchez-Cespedes J, Belda I, Vila J, Giralt E. 2008. Mechanism of binding of fluoroquinolones to the quinolone resistancedetermining region of DNA gyrase: towards an understanding of the molecular basis of quinolone resistance. Chembiochem 9:2081-2086. http://dx.doi.org/10.1002/cbic.200800041.
30. Siu LK, Lu PL, Chen JY, Lin FM, Chang SC. 2003. High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment. Antimicrob. Agents Chemother. 47:2138-2144. http://dx.doi.org/10.1128/AAC.47.7.2138-2144.2003.
31. Fong SS, Joyce AR, Palsson BO. 2005. Parallel adaptive evolution cultures of Escherichia coli lead to convergent growth phenotypes with different gene expression states. Genome Res. 15:1365-1372. http://dx.doi.org/10.1101/gr. 3832305.
32. Lee HH, Molla MN, Cantor CR, Collins JJ. 2010. Bacterial charity work leads to population-wide resistance. Nature 467:82-85. http://dx.doi.org/10. 1038/nature09354.
33. Palmer AC, Kishony R. 2013. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nat. Rev. Genet. 14:243-248. http://dx.doi.org/10.1038/nrg3351.
34. Weinreich DM, Delaney NF, Depristo MA, Hartl DL. 2006. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 312:111-114. http://dx.doi.org/10.1126/science.1123539.
35. Caroff N, Espaze E, Gautreau D, Richet H, Reynaud A. 2000. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC. J. Antimicrob. Chemother. 45:783-788. http://dx.doi.org/10.1093/jac/45.6.783.
36. Barrick JE, Yu DS, Yoon SH, Jeong H, Oh TK, Schneider D, Lenski RE, Kim JF. 2009. Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 461:1243-1247. http://dx.doi.org/10.1038/nature08480.
37. Feng Y, Händel N, De Groot M H P, Brul S, Schultsz C, Ter Kuile BH. 2014. Experimental simulation of the effects of an initial antibiotic treatment on a subsequent treatment after initial therapy failure. Antibiotics 3:49-63. http://dx.doi.org/10.3390/antibiotics3010049.
38. Chancey ST, Zahner D, Stephens DS. 2012. Acquired inducible antimicrobial resistance in Gram-positive bacteria. Future Microbiol. 7:959-978. http://dx.doi.org/10.2217/fmb.12.63.
39. Fonville NC, Ward RM, Mittelman D. 2011. Stress-induced modulators of repeat instability and genome evolution. J. Mol. Microbiol. Biotechnol. 21:36-44. http://dx.doi.org/10.1159/000332748.
40. Ter Kuile BH, Westerhoff HV. 2001. Transcriptome meets metabolome: hierarchical and metabolic regulation of the glycolytic pathway. FEBS Lett. 500:169-171. http://dx.doi.org/10.1016/S0014-5793 (01) 02613-8.
41. Huang Da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4:44-57. http://dx.doi.org/10.1038/nprot.2008.211.